These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1856813)

  • 41. Amitriptyline for the treatment of fibromyalgia: a comprehensive review.
    Rico-Villademoros F; Slim M; Calandre EP
    Expert Rev Neurother; 2015 Oct; 15(10):1123-50. PubMed ID: 26395929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy.
    Nishishinya B; Urrútia G; Walitt B; Rodriguez A; Bonfill X; Alegre C; Darko G
    Rheumatology (Oxford); 2008 Dec; 47(12):1741-6. PubMed ID: 18697829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.
    Carette S; McCain GA; Bell DA; Fam AG
    Arthritis Rheum; 1986 May; 29(5):655-9. PubMed ID: 3521612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial.
    de Zanette SA; Vercelino R; Laste G; Rozisky JR; Schwertner A; Machado CB; Xavier F; de Souza IC; Deitos A; Torres IL; Caumo W
    BMC Pharmacol Toxicol; 2014 Jul; 15():40. PubMed ID: 25052847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.
    Hannonen P; Malminiemi K; Yli-Kerttula U; Isomeri R; Roponen P
    Br J Rheumatol; 1998 Dec; 37(12):1279-86. PubMed ID: 9973149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.
    Bennett RM; Gatter RA; Campbell SM; Andrews RP; Clark SR; Scarola JA
    Arthritis Rheum; 1988 Dec; 31(12):1535-42. PubMed ID: 3058130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N of 1 randomized trials for investigating new drugs.
    Guyatt GH; Heyting A; Jaeschke R; Keller J; Adachi JD; Roberts RS
    Control Clin Trials; 1990 Apr; 11(2):88-100. PubMed ID: 2161315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antidepressants do not have better results than placebo in the treatment of fibromyalgia in Brazil.
    Bennett RM
    Curr Rheumatol Rep; 2002 Aug; 4(4):284-5. PubMed ID: 12166412
    [No Abstract]   [Full Text] [Related]  

  • 49. [Infantile fibromyalgia. Review and case report].
    Martín-Calama J; Bosque Peralta MT; Labay Matías M; Valle Sánchez F; de Miguel Pardo C; Valero Adán MT
    An Esp Pediatr; 1991 Jul; 35(1):67-8. PubMed ID: 1772176
    [No Abstract]   [Full Text] [Related]  

  • 50. Qualitative analysis of a controlled trial of qigong for fibromyalgia: advancing understanding of an emerging health practice.
    Sawynok J; Lynch M
    J Altern Complement Med; 2014 Aug; 20(8):606-17. PubMed ID: 25072523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacotherapeutics in fibrositis.
    Gatter RA
    Am J Med; 1986 Sep; 81(3A):63-6. PubMed ID: 3464210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibromyalgia · anxiety/depression · urinary retention · Dx?
    Roth-Damas P; Sempere-Manuel M; Palop-Larrea V
    J Fam Pract; 2015 Sep; 64(9):E1-3. PubMed ID: 26546961
    [No Abstract]   [Full Text] [Related]  

  • 53. In fibromyalgia, amitriptyline is comparable to FDA-approved drugs for symptoms and acceptability.
    Staud R
    Ann Intern Med; 2022 Oct; 175(10):JC118. PubMed ID: 36191311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep as a window into the world of fibromyalgia syndrome.
    Thomas RJ
    J Rheumatol; 2011 Dec; 38(12):2499-500. PubMed ID: 22134792
    [No Abstract]   [Full Text] [Related]  

  • 55. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.
    Zucker DR; Schmid CH; McIntosh MW; D'Agostino RB; Selker HP; Lau J
    J Clin Epidemiol; 1997 Apr; 50(4):401-10. PubMed ID: 9179098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some t-tests for N-of-1 trials with serial correlation.
    Tang J; Landes RD
    PLoS One; 2020; 15(2):e0228077. PubMed ID: 32017772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
    Guyatt GH; Keller JL; Jaeschke R; Rosenbloom D; Adachi JD; Newhouse MT
    Ann Intern Med; 1990 Feb; 112(4):293-9. PubMed ID: 2297206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation.
    Patel A; Jaeschke R; Guyatt GH; Keller JL; Newhouse MT
    Am Rev Respir Dis; 1991 Oct; 144(4):962-4. PubMed ID: 1928975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study.
    Albertoni Giraldes AL; Salomão R; Leal PD; Brunialti MK; Sakata RK
    Int J Rheum Dis; 2016 Oct; 19(10):946-953. PubMed ID: 27309886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial.
    Macian N; Pereira B; Shinjo C; Dubray C; Pickering G
    Trials; 2015 Apr; 16():134. PubMed ID: 25873248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.